All treatments
Treatment
Simponi 45 mg/0.45 mL solution for injection in pre-filled pen. clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedPhase III and phase IV (Integrated)
IMPACT OF ANTI-TNF, VEDOLIZUMAB AND TOFACITINIB ON AORTIC STIFFNESS, CAROTID INTIMA-MEDIA THICKNESS AND CARDIOVASCULAR RISK OF PATIENTS WITH ULCERATIVE COLITIS
This study looks at how certain medicines for ulcerative colitis might affect heart and blood vessel health. We want to see if these treatments change the thickness of neck artery walls or how stiff the main heart artery is in people with ulcerative colitis.
For: ulcerative colitisFrance - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3 Randomized, Open-Label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Golimumab Treatment, a Human anti-TNFα Monoclonal Antibody, Administered Subcutaneously in Pediatric Participants with Moderately to Severely Active Ulcerative Colitis
This study is looking at a medicine called Simponi for children and teenagers with a gut condition called ulcerative colitis. It wants to see if Simponi can help them feel better and heal their gut, and if it's safe to use.
For: Ulcerative ColitisPoland · France · Italy